Abstract:INTRODUCTION: Angiotensin (Ang) II is known to activate matrix metalloproteinases (MMPs), leading to degradation of extracellular matrix (ECM) proteins and myocardial remodelling. Angiotensin-converting enzyme-2 (ACE2) is a carboxypeptidase that metabolises Ang II to yield Ang-(1–7), essentially negatively regulating the renin-angiotensin system. We hypothesised that loss of ACE2 exacerbates myocardial remodelling by modulating the levels of MMPs. 10-week old male wildtype (WT, Ace2+/y) and ACE2 knockout (ACE2KO, Ace2−/y) mice received with mini-osmotic pumps (model 1002; USA) with a pressor dose of Ang II (1.5 mg kg−1 d−1) or saline for 2 weeks. Pro and cleaved forms of MMP2 and MMP9 were detected by gelatine zymography, and total collagenase and gelatinase activities were measured using fluorescent-based activity assays from EnzCheck (Molecular Probes). The membrane-anchored collagenase membrane type 1 (MT1)-MMP, the fibrotic factors transforming growth factor-β1 (TGF-β1) and fibronectin levels in heart were determined by TaqMan real-time PCR and western blotting analyses, respectively. In response to chronic stimulation by Ang II, there were significant increases in myocardial expression of MMP2, MMP9 and MT1-MMP in both WT and ACE2KO mice with elevated plasma Ang II levels. Furthermore, loss of ACE2 resulted in greater increases in Ang II-mediated expression of pro MMP2 and active MMP2 and MMP9 in ACE2KO hearts associated with enhanced expression of MT1-MMP, TGF-β1 and fibronectin and elevated activities of gelatinase and collagenase. These changes were linked with a degraded and disorganised ECM in the Ang II-treated ACE2KO heart by picrosirius red staining. ACE2 deficiency exacerbates Ang II-mediated adverse myocardial remodelling by modulating the levels of MMP2, MMP9 and MT1-MMP and enhancing the expression of TGF-β1 and fibronectin, implying a critical role of ACE2 in regulating the balance between generation and degradation of myocardial extracellular matrix and potential therapeutic approaches by enhancing ACE2 action for patients with heart diseases. This work was supported by National Natural Science Foundation of China (30973522 & 81170246), Shanghai Pujiang Talents Programme (11PJ1408300) and the Canadian Institute for Health Research (86602 & 84279).

Epigenetic Regulation of the N-Terminal Truncated Isoform of Matrix Metalloproteinase-2 (NTT-MMP-2) and Its Presence in Renal and Cardiac Diseases

An Intracellular Matrix Metalloproteinase-2 Isoform Induces Tubular Regulated Necrosis: Implications for Acute Kidney Injury.

Oxidative Stress Abrogates the Degradation of KMT2D to Promote Degeneration in Nucleus Pulposus.

Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury

ANGIOTENSIN II-MEDIATED MYOCARDIAL EXPRESSION OF MMP2, MMP9 AND MT1-MMP WERE ENHANCED IN ACE2-NULL MICE

Matrix metalloproteinases involvement in pathologic conditions

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

Abstract P3207: Mitoregulin Microprotein Influences Mitochondrial Membrane Integrity And Myocardial Ischemia-Reperfusion Injury

Epigenetics and expression of key genes associated with cardiac fibrosis: NLRP3, MMP2, MMP9, CCN2/CTGF and AGT

Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu

Mkp2 Inhibits Tgf-Beta 1-Induced Epithelial-To-Mesenchymal Transition In Renal Tubular Epithelial Cells Through A Jnk-Dependent Pathway

Divergent Roles of Matrix Metalloproteinase 2 in Pathogenesis of Thoracic Aortic Aneurysm

TNF-α and IL-1β–mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells

The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2

Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy

Loss of Angiotensin-Converting Enzyme 2 Exacerbates Myocardial Injury Via Activation of the CTGF-fractalkine Signaling Pathway.

Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease

Role of MMP-2 and CD147 in Kidney Fibrosis

Membrane-type 1 Matrix Metalloproteinase Modulates Tissue Homeostasis by a Non-proteolytic Mechanism

Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments

Matrix Metalloproteinases-7 and Kidney Fibrosis